Erlotinib Completed Phase 1 Trials for Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Advanced Malignant Mesothelioma / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Stage IV Basal Cell Carcinoma of the Lip / Adult Glioblastoma / Adult Primary Hepatocellular Carcinoma / Stage IV Non-Small Cell Lung Cancer / Metastatic Bladder Cancer / Adult Oligodendroglioma / Recurrent Squamous Cell Carcinoma of the Larynx / Stage IV Breast Cancer / Recurrent Lymphoepithelioma of the Nasopharynx / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Recurrent Basal Cell Carcinoma of the Lip / Stage IV Adenoid Cystic Carcinoma of the Oral Cavity / Male Breast Cancer / Stage II Pancreatic Cancer / Recurrent Colon Cancer / Adult Anaplastic Oligodendroglioma / Adult Brain Stem Glioma / Stage II Esophageal Cancer / Recurrent Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Esophageal Cancer / Adult Myxopapillary Ependymoma / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Recurrent Bladder Cancer / Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Recurrent Adult Primary Liver Cancer / Recurrent Rectal Cancer / Recurrent Malignant Mesothelioma / Adult Pilocytic Astrocytoma / Stage IV Squamous Cell Carcinoma of the Oropharynx / Stage IVA Cervical Cancer / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Stage III Pancreatic Cancer / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage III Esophageal Cancer / Adult Diffuse Astrocytoma / Stage IV Salivary Gland Cancer / Adult Gliosarcoma / Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Adult Anaplastic Astrocytoma / Stage IV Pancreatic Cancer / Metastatic Colon Cancer / Recurrent Cervical Cancer / Stage IV Verrucous Carcinoma of the Larynx / Recurrent Breast Cancer / Stage IV Prostate Cancer / Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Larynx / Unspecified Adult Solid Tumor, Protocol Specific / Recurrent Salivary Gland Cancer / Recurrent Pancreatic Cancer / Stage IV Ovarian Epithelial Cancer / Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Adult Subependymoma / Advanced Adult Primary Liver Cancer / Recurrent Ovarian Epithelial Cancer / Adult Ependymoblastoma / Stage IV Verrucous Carcinoma of the Oral Cavity / Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Stage IV Anal Cancer / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Prostate Cancer / Adult Giant Cell Glioblastoma / Recurrent Anal Cancer / Recurrent Adenoid Cystic Carcinoma of the Oral Cavity / Stage IV Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Stage IVB Cervical Cancer / Stage IIIb Non-small Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Recurrent Esophageal Cancer / Adult Anaplastic Ependymoma / Stage IV Lymphoepithelioma of the Nasopharynx / Recurrent Lymphoepithelioma of the Oropharynx / Recurrent Verrucous Carcinoma of the Oral Cavity / Adult Mixed Glioma / Recurrent Squamous Cell Carcinoma of the Oropharynx / Stage IV Lymphoepithelioma of the Oropharynx / Untreated Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Adult Brain Tumor / Stage IV Rectal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01839955Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer
NCT00088959Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00042809Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
NCT00276575Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
NCT00030498Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00126620Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00320073Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors